Literature DB >> 12031731

Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention.

Howard C Herrmann1, Tomasz A Swierkosz, Shiv Kapoor, Danielle C Tardiff, Peter M DiBattiste, John W Hirshfeld, Bruce D Klugherz, Daniel M Kolansky, Kathleen Magness, Nicholas Valettas, Robert L Wilensky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12031731     DOI： 10.1016/s0002-9149(02)02329-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

Review 1.  Comparative pharmacology of GP IIb/IIIa antagonists.

Authors:  Karsten Schrör; Artur-Aron Weber
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

Review 2.  [Haemostaseology].

Authors:  K Schrör
Journal:  Internist (Berl)       Date:  2005-08       Impact factor: 0.743

3.  Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates.

Authors:  Walter J Janse van Rensburg; Jan P Roodt; Seb Lamprecht; S Muriel Meiring; Philip N Badenhorst
Journal:  Clin Exp Med       Date:  2012-01-05       Impact factor: 3.984

Review 4.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 5.  Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.

Authors:  David J Schneider
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 6.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

7.  Intra-arterial infusion of a glycoprotein IIb/IIIa antagonist for the treatment of thromboembolism during coil embolization of intracranial aneurysm: a comparison of abciximab and tirofiban.

Authors:  H W Jeong; S-C Jin
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-09       Impact factor: 3.825
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.